We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

PERKIN ELMER CORPORATION

PerkinElmer provides detection technologies to detect and identify diseases, imaging technologies to help visualize s... read more Featured Products: More products

Download Mobile App





PerkinElmer Demonstrates High-Throughput MSMS Dried Blood Spot Screening Solutions at Medlab Middle East 2021

By LabMedica International staff writers
Posted on 21 Jun 2021
Print article
Image: PerkinElmer QSight 225 LC/MS/MS (Photo courtesy of PerkinElmer, Inc.)
Image: PerkinElmer QSight 225 LC/MS/MS (Photo courtesy of PerkinElmer, Inc.)
PerkinElmer, Inc. (Waltham, MA; USA) demonstrated its high-throughput MSMS dried blood spot screening solutions at the 2021 edition of Medlab Middle East, the leading medical laboratory exhibition in the region for over 20 years.

On display at the event was the PerkinElmer QSight 225 LC/MS/MS system developed uniquely for newborn screening with the option for tier 2 testing – using just a single heel-prick dried blood spot (DBS) card. The QSight system delivers a unique combination of self-cleaning MS/MS instrumentation that provides exceptional system uptime, a simple setup process, and easy-to-use database software that simplifies review and analysis - plus kits and reagents, training, and support. The QSight system includes a high capacity autosampler, precision binary pump, best in class MS detector, and easy to use instrument control and data analysis software that have been optimized to run hundreds of samples per day, for weeks at a time, to generate consistent results with minimum maintenance or downtime.

PerkinElmer also exhibited the Opera Phenix High Content Screening System, the premier confocal solution for today's most demanding high content applications. Drawing on over a decade of experience with the industry-leading Opera High Content Screening System, the Opera Phenix is designed for high-throughput, phenotypic screening and assays involving complex disease models, such as live cells, primary cells and microtissues. In addition, PerkinElmer highlighted the VICTOR Nivo multimode reader that breaks new ground, packing all popular detection modes into the industry’s smallest benchtop footprint. The successor to the highly popular VICTOR X system - the world’s first multimode plate reader - the VICTOR Nivo system detects absorbance, luminescence, fluorescence intensity, time-resolved fluorescence, fluorescence polarization and now Alpha technologies, making it perfect for everyday biochemical and cell-based assays, including kinetic measurements.

At this year’s Medlab Middle East, PerkinElmer displayed the LC 300 chromatography platform that redefines and simplifies LC, delivering the flexibility, performance, and efficiency to tackle challenging analytical demands. Users can choose between a 10k-psi system for HPLC and an 18k-psi system for ultraprecise UHPLC analysis. Both offer patented valve technology and sample handling options to accommodate multiple sample tray formats. And SimplicityChrom 21CFR11 software delivers intuitive instrument control, while an integrated color display shows immediate system status. Combined with CDS third-party drivers for commercial systems, this offers a powerful and simple LC solution. Also on display was the chemagic 360 instrument, with dimensions of only 80 x 80 cm and its unique sample volume flexibility, making it the ideal solution for nucleic acid isolation in human genetics, biobanking, HLA typing, viral and bacterial detection.

Related Links:
PerkinElmer, Inc.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.